SavedAdd your journal

Journals / Molecular Imaging and Radionuclide Therapy / 2015 / Cilt: 24 - Sayı: 1

Langerhans Hücreli Histiositozun Vertebral Lezyonlarını Göstermede F-18 Florodeoksiglukoz Pozitron Emisyon Tomografi ve Tanısal Bilgisayarlı Tomografi ile Karşılaştırıldığında Kemik Sintigrafisinin Yetersizliği

nsufficiency of Bone Scintigraphy in Vertebral Lesions of Langerhans Cell Histiocytosis Compared to F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Diagnostic Computed Tomography

ZEHRA PINAR KOÇ
FİKRİ SELÇUK ŞİMŞEK
Saadet AKARSU
TANSEL ANSAL BALCI
MEHMET RUHİ ONUR
Ferat KEPENEK
Pages
21–24
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present a seventeen year old male patient with disseminated LCH presented with exophtalmos and having multiple vertebral lesions which were identified by F-18 FDG PET/CT scan and diagnostic CT but not in the bone scintigraphy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Langerhans cell histiocytosis (LCH) is a benign disorder related to the histiocytes which can infiltrate bone tissue.
📊
Key Findings & Data:The most effective method for demonstrating severity of this disease is PET/CT and bone scintigraphy might show bone lesions.
💡
Conclusion & Impact:We present a seventeen year old male patient with disseminated LCH presented with exophtalmos and having multiple vertebral lesions which were identified by F-18 FDG PET/CT scan and diagnostic CT but not in the bone scintigraphy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Langerhans cell histiocytosis (LCH) is a benign disorder related to the histiocytes which can infiltrate bone tissue. The most effective method for demonstrating severity of this disease is PET/CT and bone scintigraphy might show bone lesions. We present a seventeen year old male patient with disseminated LCH presented with exophtalmos and having multiple vertebral lesions which were identified by F-18 FDG PET/CT scan and diagnostic CT but not in the bone scintigraphy.

Özet

Langerhans hücreli histiositoz (LHH) histiyositlerle ilişkili kemiği infiltre edebilen iyi huylu bir hastalıktır. Bu hastalığın yaygınlığını gösteren en etkili metod PET/BT’dir ve kemik sintigrafisi de kemik lezyonlarını gösterir. Yaygın LHH tanısı ve egzoftalmus ile takip edilen, çoklu vertebral lezyonları F-18 FDG PET/BT ve tanısal BT tetkikleri ile saptanan ancak kemik sintigrafisinde tespit edilemeyen, on yedi yaşında erkek hastayı sunmaktayız.

🔖

Cite This Article

KOÇ, Z. P., ŞİMŞEK, F. S., AKARSU, S., BALCI, T. A., ONUR, M. R., KEPENEK, F. (2015). Langerhans Hücreli Histiositozun Vertebral Lezyonlarını Göstermede F-18 Florodeoksiglukoz Pozitron Emisyon Tomografi ve Tanısal Bilgisayarlı Tomografi ile Karşılaştırıldığında Kemik Sintigrafisinin Yetersizliği. Molecular Imaging and Radionuclide Therapy, Cilt: 24 - Sayı: 1, 21–24. https://ajindex.com/articles/295154

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Sager S, Yilmaz S, Sager G, Halac M. Tc 99m bone scan and fluorodeoxyglucose positron emission tomography in evaluation of disseminated langerhans cell histiocytosis. Indian J Nucl Med 2010;25:164-167
  2. Pavlik M, Bloom DA, Ozgönenel B, Sarnaik SA. Defining the role of magnetic resonance imaging in unifocal bone lesions of langerhans cell histiocytosis. J Pediatr Hematol Oncol 2005;27:432-435
  3. Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 2009;52:97- 101
  4. Hashmi MA, Haque N, Chatterjee A, Guha S. Langerhans cell histiocytosis of long bones: MR imaging and complete follow up study. J Cancer Res Ther 2012;8:286-288
  5. Jubran RF, Marachelian A, Dorey F, Malogolowkin M. Predictors of outcome in children with Langerhans cell histiocytosis.Pediatr Blood Cancer 2005;45:37-42
  6. Kaste SC, Rodriguez-Galindo C, McCarville ME, Shulkin BL. PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Radiol 2007;37:615-622
  7. Cantu MA, Lupo PJ, Bilgi M, Hicks MJ, Allen CE, McClain KL. Optimal therapy for adults with langerhans cell histiocytosis bone lesions. PLoS One 2012;7:43257
  8. Hung YC, Chang FC, Chen YW, Liang ML, Chen HH, Hsu SP, Yang HC, Wong TT. Langerhans’ cell histiocytosis in the pediatric spine: therapeutic dynamic change of spinal deformity. Childs Nerv Syst 2012;28:1243-1250
  9. Aoki J, Watanabe H, Shinozaki T, Takagishi K, Ishijima H, Oya N, Sato N, Inoue T, Endo K. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001;219:774-777
  10. Binkovitz LA, Olshefski RS, Adler BH. Coincidence FDG-PET in the evaluation of Langerhans’ cell histiocytosis: preliminary findings. Pediatr Radiol 2003;33:598-602
  11. Yaman E, Ozturk B, Erdem O, Gokcora N, Coskun U, Uluoglu O Benekli M. Histiocytic sarcoma: PET-CT evaluation of a rare entity. Ann Nucl Med 2008; 22:715-717
  12. Azouz EM, Saigal G, Rodriguez MM, Podda A. Langerhans’ cell histiocytosis: pathology, imaging and treatment of skeletal involvement. Pediatr Radiol 2005;35:103-115
  13. Goo HW, Yang DH, Ra YS, Song JS, Im HJ, Seo JJ, Ghim T, Moon HN. Whole-body MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphy. Pediatr Radiol 2006;36:1019-1031
  14. Abdellaoui M, Benatiya AI, Bhallil S, Tahri H. Orbital location of multivisceral Langerhans-cell histiocytosis. Arch Pediatr 2011;